Association of IL-12p70 and IL-6: IL-10 ratio with autism-related behaviors in 22q11.2 deletion syndrome: A preliminary report

Brain, Behavior, and Immunity

Volumn 31, Issue , 2013, Pages 76-81

  Ross, Heather E ^a   Guo, Ying ^b   Coleman, Karlene ^c   Ousley, Opal ^a   Miller, Andrew H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Autism; Cytokines; DiGeorge syndrome; Immunity; Inflammation; Repetitive behaviors; Schizophrenia; T cell; Velo cardio facial syndrome

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ADOLESCENT; ADULT; ARTICLE; AUTISM; AUTISM DIAGNOSTIC INTERVIEW REVISED; BEHAVIOR DISORDER; CHILD; CHROMOSOME DELETION 22Q11; CLINICAL ARTICLE; COMPULSION; CORRELATION ANALYSIS; DIGEORGE SYNDROME; DISEASE SEVERITY; FEMALE; GENETIC RISK; HUMAN; IMMUNE DEFICIENCY; IMMUNOASSAY; INTERPERSONAL COMMUNICATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SCHIZOPHRENIA; SCORING SYSTEM; SOCIAL INTERACTION;

22Q11 DELETION SYNDROME; ADOLESCENT; ADULT; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; COMMUNICATION; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; MALE; SOCIAL BEHAVIOR;

EID: 84878127937     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.12.021     Document Type: Article

References (44)

1. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I., Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav. Immun. 2011, 25:40-45.
2. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I.N., Van de Water J. Altered T cell responses in children with autism. Brain Behav. Immun. 2011, 25:840-849.
3. Bilbo S.D., Schwarz J.M. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front. Behav. Neurosci. 2009, 3:14.
4. Boksa P. Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav. Immun. 2010, 24:881-897.
5. Breen E.C., Reynolds S.M., Cox C., Jacobson L.P., Magpantay L., Mulder C.B., Dibben O., Margolick J.B., Bream J.H., Sambrano E., Martinez-Maza O., Sinclair E., Borrow P., Landay A.L., Rinaldo C.R., Norris P.J. Multisite comparison of high-sensitivity multiplex cytokine assays. Clin. Vaccine Immunol. 2011, 18:1229-1242.
6. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., Babulas V.P., Susser E.S. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 2004, 61:774-780.
7. Dabitao D., Margolick J.B., Lopez J., Bream J.H. Multiplex measurement of proinflammatory cytokines in human serum: comparison of the Meso Scale Discovery electrochemiluminescence assay and the Cytometric Bead Array. J. Immunol. Methods 2011, 372:71-77.
8. Degos V., Favrais G., Kaindl A.M., Peineau S., Guerrot A.M., Verney C., Gressens P. Inflammation processes in perinatal brain damage. J. Neural Transm. 2010, 117:1009-1017.
9. Derecki N.C., Cardani A.N., Yang C.H., Quinnies K.M., Crihfield A., Lynch K.R., Kipnis J. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J. Exp. Med. 2010, 207:1067-1080.
10. Drew L.J., Crabtree G.W., Markx S., Stark K.L., Chaverneff F., Xu B., Mukai J., Fenelon K., Hsu P.K., Gogos J.A., Karayiorgou M. The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders. Int. J. Dev. Neurosci. 2011, 29:259-281.
11. Goines P.E., Croen L.A., Braunschweig D., Yoshida C.K., Grether J., Hansen R., Kharrazi M., Ashwood P., Van de Water J. Increased midgestational IFN-gamma, IL-4 and IL-5 in women bearing a child with autism: a case-control study. Mol. Autism 2011, 2:13.
12. Grether J.K., Croen L.A., Anderson M.C., Nelson K.B., Yolken R.H. Neonatally measured immunoglobulins and risk of autism. Autism Res. 2010, 3:323-332.
13. Guerreiro R.J., Santana I., Bras J.M., Santiago B., Paiva A., Oliveira C. Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment. Neurodegener. Dis. 2007, 4:406-412.
14. Hartel C., Adam N., Strunk T., Temming P., Muller-Steinhardt M., Schultz C. Cytokine responses correlate differentially with age in infancy and early childhood. Clin. Exp. Immunol. 2005, 142:446-453.
15. Hernandez R.N., Feinberg R.L., Vaurio R., Passanante N.M., Thompson R.E., Kaufmann W.E. Autism spectrum disorder in fragile X syndrome: a longitudinal evaluation. Am. J. Med. Genet. A 2009, 149A:1125-1137.
16. Heuer L., Ashwood P., Schauer J., Goines P., Krakowiak P., Hertz-Picciotto I., Hansen R., Croen L.A., Pessah I.N., Van de Water J. Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res. 2008, 1:275-283.
17. Hoffmann F., Albert M.H., Arenz S., Bidlingmaier C., Berkowicz N., Sedlaczek S., Till H., Pawlita I., Renner E.D., Weiss M., Belohradsky B.H. Intracellular T-cell cytokine levels are age-dependent in healthy children and adults. Eur. Cytokine Netw. 2005, 16:283-288.
18. Jyonouchi H., Sun S., Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J. Neuroimmunol. 2001, 120:170-179.
19. Jyonouchi H., Geng L., Ruby A., Zimmerman-Bier B. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 2005, 51:77-85.
20. Li X., Chauhan A., Sheikh A.M., Patil S., Chauhan V., Li X.M., Ji L., Brown T., Malik M. Elevated immune response in the brain of autistic patients. J. Neuroimmunol. 2009, 207:111-116.
21. Liu H., Abecasis G.R., Heath S.C., Knowles A., Demars S., Chen Y.J., Roos J.L., Rapoport J.L., Gogos J.A., Karayiorgou M. Genetic variation in the 22q11 locus and susceptibility to schizophrenia. Proc. Natl. Acad. Sci. USA 2002, 99:16859-16864.
22. Lord C., Rutter M., Le Couteur A. Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J. Autism Dev. Disord. 1994, 24:659-685.
23. McDonald-McGinn D.M., Sullivan K.E. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore) 2011, 90:1-18.
24. McDonald-McGinn, D.M., Emanuel, B.S., Zackai, E.H., 1993. 22q11.2 Deletion syndrome. In: Pagon, R.A. et al., (Eds.), University of Washington, GeneReviews. Seattle (WA).
25. McDuffie A., Abbeduto L., Lewis P., Kover S., Kim J.S., Weber A., Brown W.T. Autism spectrum disorder in children and adolescents with fragile X syndrome: within-syndrome differences and age-related changes. Am. J. Intellect. Dev. Disabil. 2010, 115:307-326.
26. McLean-Tooke A., Barge D., Spickett G.P., Gennery A.R. Immunologic defects in 22q11.2 deletion syndrome. J. Allergy Clin. Immunol. 2008, 122(362-367):367 e361-364.
27. Meechan D.W., Tucker E.S., Maynard T.M., LaMantia A.S. Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome. Proc. Natl. Acad. Sci. USA 2009, 106:16434-16445.
28. Monk C.S., Peltier S.J., Wiggins J.L., Weng S.J., Carrasco M., Risi S., Lord C. Abnormalities of intrinsic functional connectivity in autism spectrum disorders. Neuroimage 2009, 47:764-772.
29. Mortensen P.B., Pedersen C.B., Hougaard D.M., Norgaard-Petersen B., Mors O., Borglum A.D., Yolken R.H. A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring. Schizophr. Res. 2010, 122:257-263.
30. Onore C., Careaga M., Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav. Immun. 2012, 26:383-392.
31. Oskarsdottir S., Vujic M., Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch. Dis. Child. 2004, 89:148-151.
32. Parker-Athill E.C., Tan J. Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway. Neurosignals 2010, 18:113-128.
33. Pedersen M.G., Stevens H., Pedersen C.B., Norgaard-Pedersen B., Mortensen P.B. Toxoplasma infection and later development of schizophrenia in mothers. Am. J. Psychiatry 2011, 168:814-821.
34. Philip N., Bassett A. Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome. Behav. Genet. 2011, 41:403-412.
35. Reale M., Patruno A., De Lutiis M.A., Pesce M., Felaco M., Di Giannantonio M., Di Nicola M., Grilli A. Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls. BMC Neurosci. 2011, 12:13.
36. Risi S., Lord C., Gotham K., Corsello C., Chrysler C., Szatmari P., Cook E.H., Leventhal B.L., Pickles A. Combining information from multiple sources in the diagnosis of autism spectrum disorders. J. Am. Acad. Child. Adolesc. Psychiatry 2006, 45:1094-1103.
37. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1990, 1:43-46.
38. Sack U., Burkhardt U., Borte M., Schadlich H., Berg K., Emmrich F. Age-dependent levels of select immunological mediators in sera of healthy children. Clin. Diagn. Lab. Immunol. 1998, 5:28-32.
39. Singh V.K. Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J. Neuroimmunol. 1996, 66:143-145.
40. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 2007, 27:10695-10702.
41. Sorensen H.J., Mortensen E.L., Reinisch J.M., Mednick S.A. Association between prenatal exposure to bacterial infection and risk of schizophrenia. Schizophr. Bull 2009, 35:631-637.
42. Suzuki K., Matsuzaki H., Iwata K., Kameno Y., Shimmura C., Kawai S., Yoshihara Y., Wakuda T., Takebayashi K., Takagai S., Matsumoto K., Tsuchiya K.J., Iwata Y., Nakamura K., Tsujii M., Sugiyama T., Mori N. Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One 2011, 6:e20470.
43. Trollor J.N., Smith E., Agars E., Kuan S.A., Baune B.T., Campbell L., Samaras K., Crawford J., Lux O., Kochan N.A., Brodaty H., Sachdev P. The association between systemic inflammation and cognitive performance in the elderly: the Sydney memory and ageing study. Age (Dordr) 2012, 34:1295-1308.
44. Wiegering V., Eyrich M., Wunder C., Gunther H., Schlegel P.G., Winkler B. Age-related changes in intracellular cytokine expression in healthy children. Eur. Cytokine Netw. 2009, 20:75-80.